285 related articles for article (PubMed ID: 26068949)
1. Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.
Lin J; Myers AL; Wang Z; Nancarrow DJ; Ferrer-Torres D; Handlogten A; Leverenz K; Bao J; Thomas DG; Wang TD; Orringer MB; Reddy RM; Chang AC; Beer DG; Lin L
Oncotarget; 2015 Sep; 6(26):22239-57. PubMed ID: 26068949
[TBL] [Abstract][Full Text] [Related]
2. Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
Tilli TM; Mello KD; Ferreira LB; Matos AR; Accioly MT; Faria PA; Bellahcène A; Castronovo V; Gimba ER
Prostate; 2012 Nov; 72(15):1688-99. PubMed ID: 22495819
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin-c splicing isoform contributes to ovarian cancer progression.
Tilli TM; Franco VF; Robbs BK; Wanderley JL; da Silva FR; de Mello KD; Viola JP; Weber GF; Gimba ER
Mol Cancer Res; 2011 Mar; 9(3):280-93. PubMed ID: 21263033
[TBL] [Abstract][Full Text] [Related]
4. Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.
Goparaju CM; Pass HI; Blasberg JD; Hirsch N; Donington JS
J Thorac Oncol; 2010 Oct; 5(10):1516-23. PubMed ID: 20689445
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells.
Nakamura KD; Tilli TM; Wanderley JL; Palumbo A; Mattos RM; Ferreira AC; Klumb CE; Nasciutti LE; Gimba ER
Tumour Biol; 2016 Feb; 37(2):2655-63. PubMed ID: 26404131
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma.
Siddiqui AA; Jones E; Andrade D; Shah A; Kowalski TE; Loren DE; Chipitsyna G; Arafat HA
J Gastroenterol Hepatol; 2014 Jun; 29(6):1321-7. PubMed ID: 24548099
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival.
Lee GS; Salazar HF; Joseph G; Lok ZSY; Caroti CM; Weiss D; Taylor WR; Lyle AN
Lab Invest; 2019 Mar; 99(3):331-345. PubMed ID: 29959420
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of nicotine receptor and osteopontin isoforms in human pancreatic ductal adenocarcinoma.
Sullivan J; Blair L; Alnajar A; Aziz T; Chipitsyna G; Gong Q; Yeo CJ; Arafat HA
Histol Histopathol; 2011 Jul; 26(7):893-904. PubMed ID: 21630219
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern of osteopontin isoforms in malignant melanoma cell lines.
Koroknai V; Szász I; Jámbor K; Balázs M
Clin Transl Sci; 2024 Jan; 17(1):e13694. PubMed ID: 38058256
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.
Sarosiek K; Jones E; Chipitsyna G; Al-Zoubi M; Kang C; Saxena S; Gandhi AV; Sendiky J; Yeo CJ; Arafat HA
J Gastrointest Surg; 2015 Apr; 19(4):639-50. PubMed ID: 25583441
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior.
Ferreira LB; Tavares C; Pestana A; Pereira CL; Eloy C; Pinto MT; Castro P; Batista R; Rios E; Sobrinho-Simões M; Gimba ER; Soares P
Oncotarget; 2016 Aug; 7(32):52003-52016. PubMed ID: 27409830
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma.
Ferreira LB; Eloy C; Pestana A; Lyra J; Moura M; Prazeres H; Tavares C; Sobrinho-Simões M; Gimba E; Soares P
Eur J Endocrinol; 2016 Apr; 174(4):551-61. PubMed ID: 26811408
[TBL] [Abstract][Full Text] [Related]
13. Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines.
Tilli TM; Bellahcène A; Castronovo V; Gimba ER
BMC Cancer; 2014 Jun; 14():433. PubMed ID: 24928374
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells.
Ho NT; Lin SW; Lee YR; Tzeng CR; Kao SH
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499654
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines.
Silva GR; Mattos DS; Bastos ACF; Viana BPPB; Brum MCM; Ferreira LB; Gimba ERP
Mol Biol Rep; 2020 Oct; 47(10):8339-8345. PubMed ID: 33006711
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma.
Jámbor K; Koroknai V; Kiss T; Szász I; Pikó P; Balázs M
Pathol Oncol Res; 2022; 28():1610608. PubMed ID: 36091936
[TBL] [Abstract][Full Text] [Related]
19. Human osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways.
Gimba ER; Tilli TM
Cancer Lett; 2013 Apr; 331(1):11-7. PubMed ID: 23246372
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy.
Güttler A; Giebler M; Cuno P; Wichmann H; Keßler J; Ostheimer C; Söling A; Strauss C; Illert J; Kappler M; Vordermark D; Bache M
Radiother Oncol; 2013 Sep; 108(3):535-40. PubMed ID: 23891093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
